{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:46Z","timestamp":1792785046694,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chulabhorn Royal Academy","award":["FRB660044\/0240 Project code 180862"],"award-info":[{"award-number":["FRB660044\/0240 Project code 180862"]}],"id":[{"id":"https:\/\/ror.org\/03b5p6e80","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-59031-7","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:55:15Z","timestamp":1782237315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Brusatol enhances the chemotherapy efficacy of Cisplatin and Gemcitabine in KKU-100 cholangiocarcinoma cells through ROS-mediated apoptosis"],"prefix":"10.1038","volume":"16","author":[{"given":"Tueanjai","family":"Khunluck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingon","family":"Inson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chartinun","family":"Chutoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laddawan","family":"Senggunprai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auemduan","family":"Prawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornkamon","family":"Lertsuwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"11","key":"59031_CR1","doi-asserted-by":"publisher","first-page":"407","DOI":"10.4251\/wjgo.v2.i11.407","volume":"2","author":"V Cardinale","year":"2010","unstructured":"Cardinale, V. Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors. World J. Gastrointest. Oncol. 2(11), 407\u2013416 (2010).","journal-title":"World J. Gastrointest. Oncol."},{"issue":"3","key":"59031_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/MOG.0b013e3282fbf9b3","volume":"24","author":"B Sripa","year":"2008","unstructured":"Sripa, B. & Pairojkul, C. Cholangiocarcinoma: lessons from Thailand. Curr. Opin. Gastroenterol. 24(3), 349\u2013356 (2008).","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"9","key":"59031_CR3","first-page":"2209","volume":"12","author":"S Kamsa-ard","year":"2011","unstructured":"Kamsa-ard, S. et al. Trends in liver cancer incidence between 1985 and 2009, Khon Kaen, Thailand: cholangiocarcinoma. Asian Pac J Cancer Prev 12(9), 2209\u20132213 (2011).","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"59031_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jhep.2019.03.013","volume":"71","author":"P Bertuccio","year":"2019","unstructured":"Bertuccio, P. et al. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. J Hepatol 71(1), 104\u2013114 (2019).","journal-title":"J Hepatol"},{"issue":"9","key":"59031_CR5","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales, J. M. et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol 17(9), 557\u2013588 (2020).","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"59031_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/14728222.2020.1733528","volume":"24","author":"K Sato","year":"2020","unstructured":"Sato, K. et al. Cholangiocarcinoma: novel therapeutic targets. Expert Opin Ther Targets 24(4), 345\u2013357 (2020).","journal-title":"Expert Opin Ther Targets"},{"issue":"14","key":"59031_CR7","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle, J. et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N. Engl. J. Med. 362(14), 1273\u20131281 (2010).","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"59031_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/gutjnl-2023-330029","volume":"73","author":"SM Rushbrook","year":"2023","unstructured":"Rushbrook, S. M. et al. British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma. Gut 73(1), 16\u201346 (2023).","journal-title":"Gut"},{"issue":"4","key":"59031_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrc.2016.25","volume":"16","author":"PS Steeg","year":"2016","unstructured":"Steeg, P. S. Targeting metastasis. Nat. Rev. Cancer 16(4), 201\u2013218 (2016).","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"59031_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s40415-015-0135-0","volume":"38","author":"S Shukla","year":"2015","unstructured":"Shukla, S. & Mehta, A. Anticancer potential of medicinal plants and their phytochemicals: a review. Brazil. Journal of Botany 38(2), 199\u2013210 (2015).","journal-title":"Brazil. Journal of Botany"},{"key":"59031_CR11","doi-asserted-by":"publisher","first-page":"153560","DOI":"10.1016\/j.phymed.2021.153560","volume":"86","author":"KW Li","year":"2021","unstructured":"Li, K. W. et al. Brucea javanica: A review on anticancer of its pharmacological properties and clinical researches. Phytomedicine 86, 153560 (2021).","journal-title":"Phytomedicine"},{"key":"59031_CR12","doi-asserted-by":"publisher","first-page":"2360427","DOI":"10.1155\/2018\/2360427","volume":"2018","author":"Y Xiang","year":"2018","unstructured":"Xiang, Y. et al. Brusatol enhances the chemotherapy efficacy of gemcitabine in pancreatic cancer via the Nrf2 signalling pathway. Oxid Med Cell Longev 2018, 2360427 (2018).","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"59031_CR13","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1073\/pnas.1014275108","volume":"108","author":"D Ren","year":"2011","unstructured":"Ren, D. et al. Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism. Proc Natl Acad Sci U S A 108(4), 1433\u20131438 (2011).","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"59031_CR14","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1038\/s41598-021-83606-1","volume":"11","author":"HEE Khine","year":"2021","unstructured":"Khine, H. E. E. et al. Chemosensitizing activity of peptide from Lentinus squarrosulus (Mont.) on cisplatin-induced apoptosis in human lung cancer cells. Sci. Rep. 11(1), 4060 (2021).","journal-title":"Sci. Rep."},{"issue":"3","key":"59031_CR15","first-page":"1447","volume":"41","author":"HM Chen","year":"2018","unstructured":"Chen, H. M. et al. Synergistic antitumor effect of brusatol combined with cisplatin on colorectal cancer cells. Int J Mol Med 41(3), 1447\u20131454 (2018).","journal-title":"Int J Mol Med"},{"issue":"4","key":"59031_CR16","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.bbrc.2017.04.133","volume":"487","author":"Y Xiang","year":"2017","unstructured":"Xiang, Y. et al. Brusatol inhibits growth and induces apoptosis in pancreatic cancer cells via JNK\/p38 MAPK\/NF-\u03bab\/Stat3\/Bcl-2 signaling pathway. Biochem Biophys Res Commun 487(4), 820\u2013826 (2017).","journal-title":"Biochem Biophys Res Commun"},{"issue":"22","key":"59031_CR17","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.3748\/wjg.v11.i22.3392","volume":"11","author":"B Sripa","year":"2005","unstructured":"Sripa, B. et al. Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100). World J Gastroenterol 11(22), 3392\u20133397 (2005).","journal-title":"World J Gastroenterol"},{"issue":"11","key":"59031_CR18","doi-asserted-by":"publisher","first-page":"101042831772592","DOI":"10.1177\/1010428317725925","volume":"39","author":"S Saensa-Ard","year":"2017","unstructured":"Saensa-Ard, S. et al. Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand. Tumour Biol 39(11), 101042831772592 (2017).","journal-title":"Tumour Biol"},{"issue":"6","key":"59031_CR19","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1002\/ptr.5061","volume":"28","author":"L Senggunprai","year":"2014","unstructured":"Senggunprai, L. et al. Quercetin and EGCG exhibit chemopreventive effects in cholangiocarcinoma cells via suppression of JAK\/STAT signaling pathway. Phytother Res 28(6), 841\u2013848 (2014).","journal-title":"Phytother Res"},{"issue":"1","key":"59031_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1756-9966-33-11","volume":"33","author":"P Zeekpudsa","year":"2014","unstructured":"Zeekpudsa, P. et al. Suppression of NAD(P)H-quinone oxidoreductase 1 enhanced the susceptibility of cholangiocarcinoma cells to chemotherapeutic agents. J Exp Clin Cancer Res 33(1), 11 (2014).","journal-title":"J Exp Clin Cancer Res"},{"issue":"19","key":"59031_CR21","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.3748\/wjg.v16.i19.2362","volume":"16","author":"B Buranrat","year":"2010","unstructured":"Buranrat, B. Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells. World J Gastroenterol 16(19), 2362\u20132370 (2010).","journal-title":"World J Gastroenterol"},{"issue":"1","key":"59031_CR22","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3892\/ijo.2015.3240","volume":"48","author":"MA Asgar","year":"2016","unstructured":"Asgar, M. A. et al. Synergistic anticancer effects of cisplatin and histone deacetylase inhibitors (SAHA and TSA) on cholangiocarcinoma cell lines. Int J Oncol 48(1), 409\u2013420 (2016).","journal-title":"Int J Oncol"},{"issue":"9","key":"59031_CR23","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.31557\/APJCP.2019.20.9.2745","volume":"20","author":"P Choodetwattana","year":"2019","unstructured":"Choodetwattana, P. et al. The Upregulation of OCT4 in Acidic Extracellular pH is Associated with Gemcitabine Resistance in Cholangiocarcinoma Cell Lines. Asian Pac J Cancer Prev 20(9), 2745\u20132748 (2019).","journal-title":"Asian Pac J Cancer Prev"},{"issue":"18","key":"59031_CR24","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.3748\/wjg.v11.i18.2748","volume":"11","author":"N Tepsiri","year":"2005","unstructured":"Tepsiri, N. et al. Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines. World J Gastroenterol 11(18), 2748\u20132753 (2005).","journal-title":"World J Gastroenterol"},{"key":"59031_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120427","volume":"296","author":"R Jaidee","year":"2022","unstructured":"Jaidee, R. et al. Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT\/mTOR and EMT signaling pathways. Life Sci 296, 120427 (2022).","journal-title":"Life Sci"},{"key":"59031_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.biopha.2018.12.051","volume":"111","author":"O Tusskorn","year":"2019","unstructured":"Tusskorn, O. et al. Mitochondrial division inhibitor-1 potentiates cisplatin-induced apoptosis via the mitochondrial death pathway in cholangiocarcinoma cells. Biomed Pharmacother 111, 109\u2013118 (2019).","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"59031_CR27","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.58.3.10","volume":"58","author":"TC Chou","year":"2006","unstructured":"Chou, T. C. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58(3), 621\u2013681 (2006).","journal-title":"Pharmacol Rev"},{"issue":"12","key":"59031_CR28","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","volume":"1863","author":"M Redza-Dutordoir","year":"2016","unstructured":"Redza-Dutordoir, M. & Averill-Bates, D. A. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta 1863(12), 2977\u20132992 (2016).","journal-title":"Biochim Biophys Acta"},{"issue":"5\u20136","key":"59031_CR29","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/S0891-5849(99)00107-0","volume":"27","author":"H Wang","year":"1999","unstructured":"Wang, H. & Joseph, J. A. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader11Mention of a trade name, proprietary product, or specific equipment does not constitute a guarantee by the United States Department of Agriculture and does not imply its approval to the exclusion of other products that may be suitable.. Free Radic Biol Med 27(5\u20136), 612\u2013616 (1999).","journal-title":"Free Radic Biol Med"},{"issue":"9935","key":"59031_CR30","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"N Razumilava","year":"2014","unstructured":"Razumilava, N. & Gores, G. J. Cholangiocarcinoma. The Lancet 383(9935), 2168\u20132179 (2014).","journal-title":"The Lancet"},{"key":"59031_CR31","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.biopha.2018.06.065","volume":"105","author":"R Ye","year":"2018","unstructured":"Ye, R. et al. Comprehensive anti-tumor effect of Brusatol through inhibition of cell viability and promotion of apoptosis caused by autophagy via the PI3K\/Akt\/mTOR pathway in hepatocellular carcinoma. Biomed Pharmacother 105, 962\u2013973 (2018).","journal-title":"Biomed Pharmacother"},{"key":"59031_CR32","doi-asserted-by":"publisher","first-page":"152680","DOI":"10.1016\/j.tox.2021.152680","volume":"451","author":"J Xie","year":"2021","unstructured":"Xie, J. et al. Apoptotic activities of brusatol in human non-small cell lung cancer cells: Involvement of ROS-mediated mitochondrial-dependent pathway and inhibition of Nrf2-mediated antioxidant response. Toxicology 451, 152680 (2021).","journal-title":"Toxicology"},{"issue":"14","key":"59031_CR33","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.7150\/thno.20861","volume":"7","author":"ET Oh","year":"2017","unstructured":"Oh, E. T. et al. Brusatol-mediated inhibition of c-Myc increases HIF-1\u03b1 degradation and causes cell death in colorectal cancer under hypoxia. Theranostics 7(14), 3415\u20133431 (2017).","journal-title":"Theranostics"},{"issue":"11","key":"59031_CR34","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1038\/sj.leu.2402696","volume":"16","author":"E Mata-Greenwood","year":"2002","unstructured":"Mata-Greenwood, E. et al. Brusatol-mediated induction of leukemic cell differentiation and G(1) arrest is associated with down-regulation of c-myc. Leukemia 16(11), 2275\u20132284 (2002).","journal-title":"Leukemia"},{"key":"59031_CR35","doi-asserted-by":"publisher","first-page":"154323","DOI":"10.1016\/j.phymed.2022.154323","volume":"104","author":"Z Chen","year":"2022","unstructured":"Chen, Z. et al. Brusatol suppresses the growth of intrahepatic cholangiocarcinoma by PI3K\/Akt pathway. Phytomedicine 104, 154323 (2022).","journal-title":"Phytomedicine"},{"key":"59031_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020280","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Targeting NRF2-Governed Glutathione Synthesis for SDHB-Mutated Pheochromocytoma and Paraganglioma. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers12020280 (2020).","journal-title":"Cancers (Basel)"},{"key":"59031_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115020","volume":"288","author":"T Wang","year":"2022","unstructured":"Wang, T. et al. Brusatol inhibits the growth of renal cell carcinoma by regulating the PTEN\/PI3K\/AKT pathway. J Ethnopharmacol 288, 115020 (2022).","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"59031_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-020-0996-z","volume":"3","author":"Y Pei","year":"2020","unstructured":"Pei, Y. et al. Quassinoid analogs with enhanced efficacy for treatment of hematologic malignancies target the PI3K\u03b3 isoform. Commun Biol 3(1), 267 (2020).","journal-title":"Commun Biol"},{"key":"59031_CR39","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.freeradbiomed.2014.11.003","volume":"78","author":"A Olayanju","year":"2015","unstructured":"Olayanju, A. et al. Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2. Free Radic Biol Med 78, 202\u2013212 (2015).","journal-title":"Free Radic Biol Med"},{"key":"59031_CR40","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2147\/JEP.S267383","volume":"13","author":"PB Tchounwou","year":"2021","unstructured":"Tchounwou, P. B. et al. Advances in our understanding of the molecular mechanisms of action of cisplatin in cancer therapy. J Exp Pharmacol 13, 303\u2013328 (2021).","journal-title":"J Exp Pharmacol"},{"issue":"4 Suppl 11","key":"59031_CR41","first-page":"3","volume":"22","author":"W Plunkett","year":"1995","unstructured":"Plunkett, W. et al. Gemcitabine: metabolism, mechanisms of action, and self-potentiation. Semin Oncol 22(4 Suppl 11), 3\u201310 (1995).","journal-title":"Semin Oncol"},{"key":"59031_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/biom9110735","author":"V Aggarwal","year":"2019","unstructured":"Aggarwal, V. et al. Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements. Biomolecules https:\/\/doi.org\/10.3390\/biom9110735 (2019).","journal-title":"Biomolecules"},{"key":"59031_CR43","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/1479-5876-12-163","volume":"12","author":"J Zha","year":"2014","unstructured":"Zha, J. et al. Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kB pathway inhibition. J Transl Med 12, 163 (2014).","journal-title":"J Transl Med"},{"issue":"7","key":"59031_CR44","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/cdd.2008.65","volume":"15","author":"A Oberst","year":"2008","unstructured":"Oberst, A., Bender, C. & Green, D. R. Living with death: the evolution of the mitochondrial pathway of apoptosis in animals. Cell Death Differ 15(7), 1139\u20131146 (2008).","journal-title":"Cell Death Differ"},{"issue":"7","key":"59031_CR45","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nri2115","volume":"7","author":"PH Krammer","year":"2007","unstructured":"Krammer, P. H., Arnold, R. & Lavrik, I. N. Life and death in peripheral T cells. Nat Rev Immunol 7(7), 532\u2013542 (2007).","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"59031_CR46","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0092-8674(00)81589-5","volume":"94","author":"X Luo","year":"1998","unstructured":"Luo, X. et al. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94(4), 481\u2013490 (1998).","journal-title":"Cell"},{"issue":"4","key":"59031_CR47","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0092-8674(00)81590-1","volume":"94","author":"H Li","year":"1998","unstructured":"Li, H. et al. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94(4), 491\u2013501 (1998).","journal-title":"Cell"},{"issue":"4","key":"59031_CR48","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.bbamcr.2011.01.026","volume":"1813","author":"C Kantari","year":"2011","unstructured":"Kantari, C. & Walczak, H. Caspase-8 and bid: caught in the act between death receptors and mitochondria. Biochim Biophys Acta 1813(4), 558\u2013563 (2011).","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"59031_CR49","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0022-2828(03)00043-9","volume":"35","author":"DJ Hausenloy","year":"2003","unstructured":"Hausenloy, D. J. & Yellon, D. M. The mitochondrial permeability transition pore: Its fundamental role in mediating cell death during ischaemia and reperfusion. J Mol Cell Cardiol 35(4), 339\u2013341 (2003).","journal-title":"J Mol Cell Cardiol"},{"issue":"1\u20132","key":"59031_CR50","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0005-2728(98)00122-4","volume":"1366","author":"AP Halestrap","year":"1998","unstructured":"Halestrap, A. P. et al. Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart. Biochim Biophys Acta 1366(1\u20132), 79\u201394 (1998).","journal-title":"Biochim Biophys Acta"},{"key":"59031_CR51","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6528\/ac197b","author":"M Lan","year":"2022","unstructured":"Lan, M. et al. Activating caspase-8\/Bid\/ROS signaling to promote apoptosis of breast cancer cells by folate-modified albumin baicalin-loaded nanoparticles. Nanotechnology https:\/\/doi.org\/10.1088\/1361-6528\/ac197b (2022).","journal-title":"Nanotechnology"},{"issue":"5","key":"59031_CR52","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ceb.2011.05.002","volume":"23","author":"EJ Hagedorn","year":"2011","unstructured":"Hagedorn, E. J. & Sherwood, D. R. Cell invasion through basement membrane: The anchor cell breaches the barrier. Curr Opin Cell Biol 23(5), 589\u2013596 (2011).","journal-title":"Curr Opin Cell Biol"},{"issue":"4","key":"59031_CR53","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/jcb.21148","volume":"101","author":"IJ Fidler","year":"2007","unstructured":"Fidler, I. J., Kim, S. J. & Langley, R. R. The role of the organ microenvironment in the biology and therapy of cancer metastasis. J Cell Biochem 101(4), 927\u2013936 (2007).","journal-title":"J Cell Biochem"},{"issue":"1","key":"59031_CR54","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1023\/A:1013880326925","volume":"19","author":"G Kouniavsky","year":"2002","unstructured":"Kouniavsky, G. et al. Stromal extracellular matrix reduces chemotherapy-induced apoptosis in colon cancer cell lines. Clin Exp Metastasis 19(1), 55\u201360 (2002).","journal-title":"Clin Exp Metastasis"},{"issue":"3","key":"59031_CR55","first-page":"357","volume":"19","author":"T Hikawa","year":"2000","unstructured":"Hikawa, T. et al. The ability in adhesion and invasion of drug-resistant human glioma cells. J Exp Clin Cancer Res 19(3), 357\u2013362 (2000).","journal-title":"J Exp Clin Cancer Res"},{"key":"59031_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119907","volume":"284","author":"J Zhou","year":"2021","unstructured":"Zhou, J. et al. Brusatol inhibits laryngeal cancer cell proliferation and metastasis via abrogating JAK2\/STAT3 signaling mediated epithelial-mesenchymal transition. Life Sci 284, 119907 (2021).","journal-title":"Life Sci"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59031-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59031-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59031-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:04:16Z","timestamp":1789520656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59031-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["59031"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-59031-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"28862"}}